Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 309

1.

Long-term experience with GH replacement therapy: efficacy and safety.

Monson JP.

Eur J Endocrinol. 2003 Apr;148 Suppl 2:S9-14. Review.

PMID:
12670295
[PubMed - indexed for MEDLINE]
Free Article
2.

Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.

Florakis D, Hung V, Kaltsas G, Coyte D, Jenkins PJ, Chew SL, Grossman AB, Besser GM, Monson JP.

Clin Endocrinol (Oxf). 2000 Oct;53(4):453-9.

PMID:
11012570
[PubMed - indexed for MEDLINE]
3.

Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database.

Monson JP, Abs R, Bengtsson BA, Bennmarker H, Feldt-Rasmussen U, Hernberg-Stâhl E, Thorén M, Westberg B, Wilton P, Wüster C.

Clin Endocrinol (Oxf). 2000 Sep;53(3):281-9.

PMID:
10971444
[PubMed - indexed for MEDLINE]
4.

GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety.

Abs R, Bengtsson BA, Hernberg-Stâhl E, Monson JP, Tauber JP, Wilton P, Wüster C.

Clin Endocrinol (Oxf). 1999 Jun;50(6):703-13.

PMID:
10468941
[PubMed - indexed for MEDLINE]
5.

Gender difference in the response of growth hormone (GH)-deficient adults to GH therapy.

Hayes FJ, Fiad TM, McKenna TJ.

Metabolism. 1999 Mar;48(3):308-13.

PMID:
10094105
[PubMed - indexed for MEDLINE]
6.

Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.

Feldt-Rasmussen U, Wilton P, Jonsson P; KIMS Study Group; KIMS International Board.

Growth Horm IGF Res. 2004 Jun;14 Suppl A:S51-8.

PMID:
15135778
[PubMed - indexed for MEDLINE]
7.

The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study.

Drake WM, Rodríguez-Arnao J, Weaver JU, James IT, Coyte D, Spector TD, Besser GM, Monson JP.

Clin Endocrinol (Oxf). 2001 Apr;54(4):525-32.

PMID:
11318789
[PubMed - indexed for MEDLINE]
8.

Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.

Abs R, Feldt-Rasmussen U, Mattsson AF, Monson JP, Bengtsson BA, Góth MI, Wilton P, Koltowska-Häggström M.

Eur J Endocrinol. 2006 Jul;155(1):79-90.

PMID:
16793953
[PubMed - indexed for MEDLINE]
Free Article
9.

[Efficacy, safety and compliance of long-term growth hormone (GH) replacement therapy in adults with GH deficiency].

Zaninelli DC, Meister LH, Radominski RB, Borba VZ, Souza AM, Boguszewski CL.

Arq Bras Endocrinol Metabol. 2008 Jul;52(5):879-88. Portuguese.

PMID:
18797596
[PubMed - indexed for MEDLINE]
Free Article
10.

Long-term growth hormone replacement therapy in hypopituitary adults.

Verhelst J, Abs R.

Drugs. 2002;62(16):2399-412. Review.

PMID:
12396230
[PubMed - indexed for MEDLINE]
11.

Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency.

Götherström G, Bengtsson BA, Bosaeus I, Johannsson G, Svensson J.

Eur J Endocrinol. 2007 Jan;156(1):55-64.

PMID:
17218726
[PubMed - indexed for MEDLINE]
Free Article
12.

Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults.

al-Shoumer KA, Gray R, Anyaoku V, Hughes C, Beshyah S, Richmond W, Johnston DG.

Clin Endocrinol (Oxf). 1998 Jun;48(6):795-802.

PMID:
9713570
[PubMed - indexed for MEDLINE]
13.

Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database).

Verhelst J, Kendall-Taylor P, Erfurth EM, Price DA, Geffner M, Koltowska-Häggström M, Jönsson PJ, Wilton P, Abs R.

J Clin Endocrinol Metab. 2005 Aug;90(8):4636-43. Epub 2005 May 31.

PMID:
15928246
[PubMed - indexed for MEDLINE]
14.

One year of GH replacement therapy with a fixed low-dose regimen improves body composition, bone mineral density and lipid profile of GH-deficient adults.

Boguszewski CL, Meister LH, Zaninelli DC, Radominski RB.

Eur J Endocrinol. 2005 Jan;152(1):67-75.

PMID:
15762189
[PubMed - indexed for MEDLINE]
Free Article
15.

Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.

Fideleff HL, Boquete HR, Stalldecker G, Giaccio AV, Sobrado PG.

Growth Horm IGF Res. 2008 Aug;18(4):318-24. doi: 10.1016/j.ghir.2008.01.002. Epub 2008 Mar 4.

PMID:
18289903
[PubMed - indexed for MEDLINE]
16.

Health-related quality of life and IGF-1 in GH-deficient adult patients on GH replacement therapy: analysis of the German KIMS data and the Study of Health in Pomerania.

Moock J, Albrecht C, Friedrich N, Völzke H, Nauck M, Koltowska-Haggström M, Kohlmann T, Wallaschofski H.

Eur J Endocrinol. 2009 Jan;160(1):17-24. doi: 10.1530/EJE-08-0738. Epub 2008 Oct 30.

PMID:
18974232
[PubMed - indexed for MEDLINE]
Free Article
18.

Long-term effects of growth hormone therapy on intermediary metabolism and insulin sensitivity in hypopituitary adults.

Johnston DG, Al-Shoumer KA, Chrisoulidou A, Kousta E, Beshyah S, Robinson S.

J Endocrinol Invest. 1999;22(5 Suppl):37-40. Review.

PMID:
10442569
[PubMed - indexed for MEDLINE]
19.

Bone density and turnover in young adult patients with growth hormone deficiency after 2-year growth hormone replacement according with gender.

Rota F, Savanelli MC, Tauchmanova L, Savastano S, Lombardi G, Colao A, Di Somma C.

J Endocrinol Invest. 2008 Feb;31(2):94-102.

PMID:
18362499
[PubMed - indexed for MEDLINE]
20.

Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.

Tanriverdi F, Unluhizarci K, Kula M, Guven M, Bayram F, Kelestimur F.

Growth Horm IGF Res. 2005 Jun;15(3):231-7.

PMID:
15921942
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk